ERIC 2018 | Prognostic markers and MRD in CLL

Robin Foà

Speaking from the European Research Initiative on Chronic Lymphocytic Leukemia (ERIC) International Meeting 2018, held in Barcelona, Spain, Robin Foà, MD, of the Sapienza University of Rome, Rome, Italy, discusses the key prognostic markers and measurable residual disease in chronic lymphocytic leukemia.

Share this video